Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Dr. Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Dr. Ricardo S. Osorio is a tenured Associate Professor of Psychiatry and Radiology at NYU Grossman School of Medicine, where he directs the Healthy Brain Aging and Sleep Center and serves as Director of the Biomarker Core within the NYU Alzheimer’s Disease Research Center. A physician-scientist, Dr. Osorio investigates the interplay of sleep, vascular, and inflammatory mechanisms in Alzheimer’s disease, integrating multimodal biomarkers, neuroimaging, and detailed clinical phenotyping. He has led several landmark studies, including trials on sleep apnea, amyloid and tau accumulation, brain energetics, and locus coeruleus dysfunction, exploring how sleep and metabolic factors influence cognitive decline and neurodegeneration. His work has significantly advanced translational biomarker development, assay harmonization, and inclusive recruitment in aging research. Dr. Osorio has published over 130 peer-reviewed articles in top journals such as JAMA Neurology, Annals of Neurology, Sleep, Alzheimer’s & Dementia, Lancet, and Brain, contributing to more than 8,369 citing documents, with a total citation count of 9,893 and an h-index of 44. He serves on multiple editorial boards, including Sleep Medicine Reports, and has provided expert peer review for leading journals worldwide. His collaborative network spans the NYU Alzheimer’s Disease Research Center, Mount Sinai, the ENIGMA-Sleep Consortium, and numerous national and international aging and sleep research initiatives, mentoring the next generation of clinician-scientists while shaping the field of sleep and neurodegeneration.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

  1. Author(s). (Year). Disordered sleep and painful diabetic neuropathy (PDN): A review of the literature on pathophysiology, pharmacologic and nonpharmacologic treatment options, and future directions. Journal Name, Volume(Issue), pages.

  2. Author(s). (2025). EEG slow oscillations and overnight spatial navigational memory performance in CPAP-treated obstructive sleep apnea. Sleep, Volume(Issue), pages.

  3. Author(s). (2025). High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer’s disease dementia. Alzheimer’s & Dementia, Volume(Issue), pages.

  4. Author(s). (2025). Impact of Alzheimer’s disease on sleep in adults with Down syndrome. Alzheimer’s & Dementia, Volume(Issue), pages.

  5. Author(s). (2025). Sleep-wake variation in body temperature regulates tau secretion and correlates with CSF and plasma tau. Journal of Clinical Investigation, Volume(Issue), pages.

  6. Author(s). (2025). The stability of slow-wave sleep and EEG oscillations across two consecutive nights of laboratory polysomnography in cognitively normal older adults. Journal of Sleep Research, Volume(Issue), pages.

  7. Author(s). (2025). Two-year longitudinal outcomes of subjective cognitive decline in Hispanics compared to non-Hispanic Whites. Journal of Geriatric Psychiatry and Neurology, Volume(Issue), pages.

  8. Author(s). (Year). Enhancing sleep, wakefulness, and cognition with transcranial photobiomodulation: A systematic review. Journal Name, Volume(Issue), pages.

  9. Author(s). (2024). The relationship between anxiety and levels of Alzheimer’s disease plasma biomarkers. Journal of Alzheimer’s Disease, Volume(Issue), pages.

  10. Author(s). (2024). The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people. Immunity and Ageing, Volume(Issue), pages.

Zhou Yu | Behavioral Neuroscience | Best Researcher Award

Dr. Zhou Yu | Behavioral Neuroscience | Best Researcher Award

Dr. Yu Zhou is a postdoctoral researcher at Army Engineering University, specializing in the intersection of neuroscience, computer vision, and target detection. His research primarily focuses on deceptive visual design for both human and machine perception, exploring how visual stimuli can influence detection, recognition, and cognitive processing. Zhou has conducted pioneering studies on camouflage and optical deception, utilizing EEG-based brain functional network analysis to evaluate target visibility and cognitive responses. His work integrates principles from weapon science, biomedical engineering, and computer science to develop comprehensive models of visual perception and deception. Representative publications include investigations into neural responses to camouflage targets with varying exposure signs, the impact of color differences on brain activation patterns, and feasibility assessments of optical camouflage effects. Through these studies, he contributes to a deeper understanding of how visual designs can manipulate human attention and computer vision systems, providing actionable insights for defense technology applications. Zhou’s research emphasizes rigorous quantitative evaluation methods, leveraging neurophysiological data to inform the design of effective deceptive visual patterns. With an h-index of 2 and multiple citations, his work demonstrates a growing influence in fields spanning neuroscience-informed computer vision, perceptual deception, and applied optical camouflage.

Profiles: Scopus | Reasearch Gate

Featured publication

Author(s). (2024). Neural responses to camouflage targets with different exposure signs based on EEG. Neuropsychologia.

Dipesh | Computational Neuroscience | Best Researcher Award

Assist. Prof. Dr. Dipesh | Computational Neuroscience | Best Researcher Award

Assist. Prof. Dr. Dipesh | SR University | India

Dr. Dipesh is a dedicated mathematician specializing in mathematical modeling, with extensive experience in both academic and research domains. He has made significant contributions to applied mathematics, particularly in areas intersecting numerical methods, AI/ML, and fluid dynamics. Dr. Dipesh has actively organized and coordinated multiple academic programs, including national workshops, faculty development programs, and departmental initiatives, demonstrating strong leadership in fostering educational and research excellence. His efforts in coordinating the Department of Intellectual Property Rights and successfully conducting events such as RAFAS highlight his commitment to academic growth and institutional development. Academically, he has pursued rigorous training from undergraduate to postdoctoral levels, culminating in advanced research at Harran University, Turkey. Dr. Dipesh’s scholarly output includes 30 documents that have been cited 103 times, reflecting an h-index of 7, underscoring the impact and relevance of his research contributions in applied mathematics and related interdisciplinary fields. His approach emphasizes quality teaching, student placement, institutional ranking, and enhancing the overall goodwill of the organizations he serves. Driven by a passion for tackling challenges and improving systems with limited resources, Dr. Dipesh continually seeks to connect with external environments, promote collaborative work, and advance the reach and recognition of academic institutions.

Profiles: Scopus | Orcid | Google Scholar | Research Gate | Linked In

Featured Publications

  1. Mathematical model of Cynodon Dactylon’s allelopathic effect on perennial ryegrass for exploring plant-plant interactions based upon ordinary differential equations. (2025). Partial Differential Equations in Applied Mathematics.

  2. Modelling the role of delay in blood flow dynamics in human body using delay differential equations. (2025). Physica A: Statistical Mechanics and Its Applications.

  3. On the modeling the impact of delay on stock pricing fluctuations using delay differential equations. (2025). Physica A: Statistical Mechanics and Its Applications.

Lingbo Li | clinical neurology | Best Researcher Award

Prof. Lingbo Li | Clinical Neurology | Best Researcher Award

Prof. Lingbo Li | Tianjin Dexiang Biotechnology Co., Ltd. | China

Prof. Li Lingbo is a leading researcher in hematology and clinical neurology, with significant contributions to blood transfusion, laboratory medicine, and neurological disorder research. Over the past five years, he has published five SCI-indexed journal articles with a cumulative impact factor of 12.09, and six journals in total, contributing to a strong citation record that includes pivotal works such as the discovery of novel mutations within human ABO and RhD antigen genes, documented in the International Gene Database (GeneBank). He has edited and published three monographs, including An Introduction to Blood Group, advancing knowledge in blood group biology and transfusion medicine. His research portfolio encompasses three completed or ongoing research projects and three consultancy or industry collaborations, alongside one patent under process. Prof. Li serves as a peer reviewer for multiple prestigious journals, including the Chinese Journal of Blood Transfusion, Chinese Journal of Preventive Medicine, and the World Journal of Psychiatry (SCI, IF 3.9/Q1). He holds memberships in Sigma Xi, the Baikouen Spirit Research Society, and the Jilin Provincial Health Management Blood Transfusion Committee. With an h-index reflecting his scholarly influence, Prof. Li continues to advance the diagnosis, treatment, and prevention of blood and neurological disorders while developing innovative therapies and interventions, establishing him as a prominent figure in translational and clinical research.

Profile: Orcid

Featured Publication

Zhong, J., Gao, Y., Mo, C., Zhang, Y., Luo, Y., & Li, L. (2025). From Rh blood group antigen antibody testing to “transfusionomics.” European Journal of Haematology.

Noreen Kamal | Translational Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Noreen Kamal | Translational Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Noreen Kamal | Dalhousie University | Canada

Dr. Noreen Kamal, Ph.D., P.Eng., is an Associate Professor of Industrial Engineering at Dalhousie University, Canada, with cross-appointments in the Departments of Community Health and Epidemiology and Medicine (Neurology). Her research lies at the intersection of health systems engineering and clinical neuroscience, focusing on the optimization of stroke care systems, development of data-driven quality improvement frameworks, and evaluation of biomedical devices for stroke rehabilitation. Dr. Kamal has played a pivotal role in advancing integrated approaches to enhance the efficiency, safety, and accessibility of acute stroke services across Canada. Prior to joining Dalhousie University, she held academic and leadership positions at the University of Calgary and the University of British Columbia, contributing extensively to clinical research and health technology innovation. Her work bridges engineering, medicine, and health policy, emphasizing interdisciplinary collaboration and patient-centered outcomes. With 107 scientific publications, 8,033 citations, and an h-index of 22, Dr. Kamal has established herself as a recognized scholar in healthcare systems improvement and translational neuroscience. Her scholarly and professional contributions continue to drive evidence-based innovation in stroke systems of care, supporting better clinical outcomes and sustainable health service delivery.

Profiles: Scopus | Google Scholar | Research Gate | Linked In

Featured Publications

Author(s). (2025). Exploring differences in stroke treatment between urban and rural hospitals: A thematic analysis of practices in Canada. Canadian Journal of Neurological Sciences.

Author(s). (2025). Designing a patient outcome clinical assessment tool for modified Rankin Scale: “You feel the same way too”. Informatics.

Author(s). (2025). Predicting ischemic stroke patients to transfer for endovascular thrombectomy using machine learning: A case study. Healthcare (Switzerland).

Author(s). (2025). Incident prescriptions for common cardiovascular medications: Comparison of recent versus pre-2020 medication adherence and discontinuation in three universal health care systems. BMC Cardiovascular Disorders.

Author(s). (2025). Rising out-of-hospital mortality in Canada during 2020–2022: A striking impact observed among young adults. Canadian Journal of Public Health.

Author(s). (2025). Discrete event simulation model of an acute stroke treatment process at a comprehensive stroke center: Determining the ideal improvement strategies for reducing treatment times. Journal of the Neurological Sciences.

Author(s). (2025). Validation of the Passive Surveillance Stroke Severity Score in three Canadian provinces. Canadian Journal of Neurological Sciences.

Author(s). (2025). A stochastic optimization model for designing disaster relief networks with congestion, disruption and distributional ambiguity. Infor.

Author(s). (2025). Improving access and efficiency of acute ischemic stroke treatment across four Canadian provinces: A stepped-wedge trial. Frontiers in Neurology.

Author(s). (2025). The acute stroke system of treatment across Canada: Findings from a national stroke centre survey. Canadian Journal of Neurological Sciences.

Dongxia Zhu | Neurogenetics | Best Researcher Award

Prof. Dongxia Zhu | Neurogenetics | Best Researcher Award

Prof. Dongxia Zhu | The Northeast Normal University | China

Prof. Dongxia Zhu is a full professor in the Department of Chemistry at Northeast Normal University, specializing in functional organic and polymeric photoelectric materials and devices. She earned her Ph.D. in Chemistry under the supervision of Prof. Zhong-Min Su at NENU and pursued joint doctoral research at Jilin University under Prof. Yue Wang. She also served as an academic visitor at Durham University, UK, collaborating with Prof. Martin R. Bryce and Prof. Todd B. Marder. Prof. Zhu has conducted extensive research on the design and development of high-performance luminescent materials, leading to the creation of highly selective and sensitive fluorescent and phosphorescent probes applied in photodynamic cancer therapy, biological imaging, and luminescence sensing. She has completed 12 research projects, published 50 SCI-indexed papers, authored one book chapter, and holds 12 patents. Her scholarly work has achieved 4,574 citations across 3,698 documents, with 123 publications and an h-index of 38. Prof. Zhu is an active member of the Chinese Chemical Society, contributing significantly to advancements in luminescent materials and their biomedical and photoelectric applications.

Profile: Scopus

Featured Publications

Wang, Z., Li, Y., Zhang, H., Jiang, N., Xu, J., Zhu, D., & Bryce, M. R. (2025). Non-traditional luminescent polyurethanes of n–π electron hybrid structures with varying separation of aromatic rings. ACS Applied Polymer Materials, 7(18), 12337–12344.


Zhu, D., Chen, X., Wang, J., & Li, Q. (2025). A new strategy enabling combined fluorescence imaging of individual tuberculous granulomas and precise photothermal therapy of tuberculosis with lesion- and pathogen-targeting capabilities of the nanoparticles. Note, Open Access.


Wang, Z., Wang, W., Wu, Q., & Zhu, D. (2025). Constructing 1 + 1 > 2 photosensitizers based on NIR cyanine–iridium(III) complexes for enhanced photodynamic cancer therapy. Molecules, 30(12), 2662.


Sun, Y., Tang, Y., Zhang, L., Zhao, H., Wang, Z., & Zhu, D. (2025). Self-assembly versus coassembly: An amphiphilic NIR-II aggregation-induced emission luminogen for phototheranostics of orthotopic glioblastoma. Journal of Medicinal Chemistry.


Wang, Z., Liu, Y., Zhao, L., Tang, Y., & Zhu, D. (2025). Endogenous near-infrared chemiluminescence: Imaging-guided non-invasive thrombolysis and anti-inflammation based on a heteronuclear transition metal complex. Advanced Science, 12(5), 14567.


Wang, Z., Li, C., Zhao, H., Tang, Y., & Zhu, D. (2025). Leveraging tumor microenvironment to boost synergistic photodynamic therapy, ferroptosis anti-tumor efficiency based on a functional iridium(III) complex. Advanced Science, 12(7), 14892.


Tang, Y., Wang, Z., Zhao, H., Sun, Y., & Zhu, D. (2025). Sonodynamic and bioorthogonal sonocatalytic thrombotic therapy based on AIE cationic tetranuclear Ir(III) complex nanoplatform guided by NIR-chemiluminescence imaging. Advanced Materials, 37(4), 2310674.


Zhu, D., Wang, Z., & Tang, Y. (2025). The Midas touch by internal stimuli: Activatable luminogens with near-infrared aggregation-induced emission for potent bioimaging and theranostics. Review Article.


Wang, Z., Li, X., Zhao, H., Tang, Y., & Zhu, D. (2024). Disulfide-bridged cationic dinuclear Ir(III) complex with aggregation-induced emission and glutathione-consumption properties for elevating photodynamic therapy. Inorganic Chemistry, 63(22), 18945–18956.


Wang, Z., Tang, Y., Zhao, H., & Zhu, D. (2024). Phosphorescent sensor based on iridium(III) complex with aggregation-induced emission activity for facile detection of volatile acids. Molecules, 29(9), 2031.

Congbo Cai | Neurotechnology | Best Researcher Award

Prof. Dr. Congbo Cai | Neurotechnology | Best Researcher Award

Prof. Dr. Congbo Cai | Xiamen University | China

Professor Congbo Cai is a distinguished researcher at the School of Electronic Science and Technology, Xiamen University, specializing in advanced Magnetic Resonance Imaging (MRI) technology development. His research encompasses ultra-fast imaging, multi-parametric quantitative MRI, deep learning reconstruction, novel neuroimaging techniques, and quantitative medical image analysis. He has led and contributed to numerous high-impact projects, including national key R&D programs, NSFC key projects, and international cooperative projects, with funding totaling several million yuan. His innovations include pioneering high-entropy encoding and overlapping-echo designs, enabling rapid, high-fidelity MRI mapping, and integrating physics-informed deep learning for enhanced image reconstruction and clinical applications. Professor Cai has published over 80 papers in leading journals such as NeuroImage, IEEE Transactions on Medical Imaging, and Medical Image Analysis. He holds 12 patents and serves on editorial boards, including Health and Metabolism, and as a guest editor for Frontiers in Neuroscience. His professional contributions extend to active membership and leadership roles in major MRI societies. His work has garnered significant academic recognition, with a citation count exceeding 2,300 across 872 documents, an h-index of 25, and an i10-index of 55. Professor Cai’s research continues to advance MRI science, bridging cutting-edge technology and clinical translation.

Profiles: Scopus | Google Scholar | Research Gate | Linked In

Featured publications

  • Author(s). (2018). Accelerating multi-slice spatiotemporally encoded MRI with simultaneous echo refocusing. Journal of Magnetic Resonance.

  • Author(s). (2018). Single-shot T2 mapping using overlapping-echo detachment planar imaging and a deep convolutional neural network. Magnetic Resonance in Medicine.

  • Author(s). (2018). Referenceless distortion correction of gradient-echo echo-planar imaging under inhomogeneous magnetic fields based on a deep convolutional neural network. Computers in Biology and Medicine.

  • Author(s). (2018). Weighted total variation using split Bregman fast quantitative susceptibility mapping reconstruction method. Chinese Physics B.

  • Author(s). (2018). Simultaneous single- and multi-contrast super-resolution for brain MRI images based on a convolutional neural network. Computers in Biology and Medicine.

  • Author(s). (2018). Motion-tolerant diffusion mapping based on single-shot overlapping-echo detachment (OLED) planar imaging. Magnetic Resonance in Medicine.

Nasar Ata | Neurology | Best Researcher Award

Mr. Nasar Ata | Neurology | Best Researcher Award

Dr. S. M. Nasar Ata is a researcher in the Department of Neurology at Henry Ford Hospital, Detroit, USA, specializing in artificial intelligence applications in neuroscience. His work focuses on developing machine learning and soft computing–based algorithms such as CNN, ANN, SVM, and MLR for detecting and predicting brain-based disorders, including Multiple Sclerosis. He integrates metabolomics and imaging clinical data to identify biomarkers and construct predictive models for neurological and metabolic diseases. Dr. Ata collaborates with research centers such as JNMC and IBRC AMU on brain tumor prediction from MRI data and with RCDR AMU on diabetes-related model development. His research contributions include several submitted papers on metabolite prediction, deep learning in brain tumor detection, and molecular mechanisms underlying neurodegeneration and cancer. He has also authored the textbook Basics of Bio-Sciences and actively participates in scientific discussions and editorial work. With 3 published documents, 7 citations, and an h-index of 2, Dr. Ata’s growing research profile reflects his commitment to advancing data-driven neurological diagnostics through AI and biostatistical innovation.

Profiles: Scopus | Research Gate

Featured Publication

Corrigendum to “Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics data” [Multiple Sclerosis and Related Disorders, 92, 105942 (2024)]. (2024). Multiple Sclerosis and Related Disorders, 95, 106321.

Chahra Chbili | Clinical Neuroscience | Best Researcher Award

Assist. Prof. Dr. Chahra Chbili | Clinical Neuroscience | Best Researcher Award

Assist. Prof. Dr. Chahra Chbili | University of Sousse | Tunisia

Dr. Chahra Chbili is an Assistant Professor of Pharmacology at the Higher School of Health Sciences and Techniques of Sousse (ESSTSS) and a member of the Research Laboratory of Metabolic Biophysics and Applied Pharmacology (LR/12ES02) at the Faculty of Medicine Ibn El Jazzar of Sousse, Tunisia. Her academic journey spans extensive training in biological sciences, genetics, and medical biotechnology, with a Ph.D. earned with highest honors for her work on the pharmacokinetic and pharmacogenetic study of carbamazepine therapy in epileptic and bipolar patients. Dr. Chbili’s research focuses on pharmacogenetics, pharmacokinetics, and the molecular mechanisms underlying drug efficacy and toxicity. She has contributed significantly to studies exploring the genetic determinants of drug metabolism, including investigations into glutathione-S-transferases in tuberculosis patients with drug-induced hepatotoxicity. Skilled in advanced laboratory techniques such as PCR, FISH, ELISA, and HPLC-MS, she has developed expertise in integrating molecular biology with clinical pharmacology. Dr. Chbili has authored 17 scientific documents, accumulated 138 citations across 123 indexed works, and maintains an h-index of 7, reflecting her impactful contributions to pharmacological and biomedical research in Tunisia and beyond.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

Chbili, C., Mrad, S., Graiet, H., Selmi, M., Maatoug, J., Maoua, M., Abdellaoui, L., Mrizek, N., Nouira, M., Ben Fredj, M., et al. (2024). Randomized, placebo-controlled pilot study investigating the effects of Laurus nobilis tea on lipid profiles and oxidative stress biomarkers in healthy North African volunteers. The North African Journal of Food and Nutrition Research, 8(17), 86–98.

Chbili, C., Fathallah, N., Laadhari, C., Ouni, B., Saguem, S., Ben Fredj, M., Abdelghani, A., Ben Saad, H., & Ben Salem, C. (2022). Glutathione-S-transferase genetic polymorphism and risk of hepatotoxicity to antitubercular drugs in a North-African population: A case-control study. Gene, 808, 146019.

Rebai, A., Chbili, C., Ben Amor, S., Hassine, A., Ben Ammou, S., & Saguem, S. (2021). Effects of glutathione S-transferase M1 and T1 deletions on Parkinson’s disease risk among a North African population. Revue Neurologique, 177(1–2), 93–99.

Chbili, C. (2021, August 22). The effect of Origanum majorana tea on motor and non-motor symptoms in patients with idiopathic Parkinson’s disease: A randomized controlled pilot study. Journal article.

Chbili, C., Maoua, M., Selmi, M., Mrad, S., Khairi, H., Limem, K., Mrizek, N., Saguem, S., & Ben Fredj, M. (2020). Evaluation of daily Laurus nobilis tea consumption on lipid profile biomarkers in healthy volunteers. Journal of the American College of Nutrition, 39(6), 518–526.

Rebai, A., Reçber, T., Nemutlu, E., Chbili, C., Kurbanoglu, S., Kir, S., Ben Amor, S., Özkan, S. A., & Saguem, S. (2020). GC-MS based metabolic profiling of Parkinson’s disease with glutathione S-transferase M1 and T1 polymorphism in Tunisian patients. Combinatorial Chemistry and High Throughput Screening, 23(8), 785–794.

Lin Xiao | Cellular Neuroscience | Best Researcher Award

Dr. Lin Xiao | Cellular Neuroscience | Best Researcher Award

Dr. Lin Xiao | Institute for Brain Research and Rehabilitation | China

Dr. Lin Xiao is a distinguished Professor of Neuroscience at the Institute for Brain Research and Rehabilitation, South China Normal University, whose pioneering research has significantly advanced understanding of oligodendrocyte biology and myelin plasticity. His work elucidates the mechanisms by which adaptive myelination contributes to motor learning and memory, proposing a novel “biphasic plasticity model” that distinguishes distinct phases of learning and consolidation. Dr. Xiao’s research has been published in leading journals including Nature Neuroscience, Science, Nature Communications, and Advanced Science, collectively garnering over 2,800 citations and an h-index of 28, with approximately 20 peer-reviewed articles. His landmark paper in Nature Neuroscience has become a classic reference with over 500 citations, demonstrating substantial influence in the field. He has led multiple projects funded by the National Natural Science Foundation of China, including completed and ongoing studies, and established major collaborations with institutions such as University College London. His research areas include glial–neuron interactions, mechanisms of remyelination, neurodevelopmental disorders such as autism, and psychiatric disorders including depression. These contributions have been recognized with national awards and have opened promising avenues for therapeutic strategies in demyelinating and cognitive disorders.

Profiles: Google Scholar | Orcid | Research Gate  

Featured Publications

Marques, S., Zeisel, A., Codeluppi, S., Van Bruggen, D., Mendanha Falcão, A., et al. (2016). Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science, 352(6291), 1326–1329.

Xiao, L., Ohayon, D., McKenzie, I. A., Sinclair-Wilson, A., Wright, J. L., Fudge, A. D., et al. (2016). Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning. Nature Neuroscience, 19(9), 1210–1217.

Liu, S., Yu, M., He, Y., Xiao, L., Wang, F., Song, C., Sun, S., Ling, C., & Xu, Z. (2008). Melittin prevents liver cancer cell metastasis through inhibition of the Rac1‐dependent pathway. Hepatology, 47(6), 1964–1973.

Li, C., Xiao, L., Liu, X., Yang, W., Shen, W., Hu, C., Yang, G., & He, C. (2013). A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination. Glia, 61(5), 732–749.

Feng, P. A. N. (2003). Fast mode decision for intra prediction. JVT-G013, March 2003.

Li, Y. X., Ding, S. J., Xiao, L., Guo, W., & Zhan, Q. (2008). Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1α and erythropoietin. Neuroscience Bulletin, 24(2), 89–95.